Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,528.52
(
2.91%
)
US TECH 100
23,080.80
(
3.36%
)
Dow Jones
46,341.51
(
2.49%
)
Brent Oil
103.14
(
-5.00%
)
Bitcoin
68,208.50
(
2.26%
)
News Focus
News Focus
Post# of 257322
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122830
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: 57_2001 post# 238441

Friday, 06/18/2021 5:36:19 PM

Friday, June 18, 2021 5:36:19 PM

Post# of 257322
ENTA’s enterprise value (@$45.74) is about $675M, based on 24.1M fully-diluted shares (#msg-163910230) and pro forma cash of $426M (#msg-163910195).

If you deduct a reasonable figure for the present value of the Mavyret royalty stream, the resulting adjusted EV is pretty close to zero. I doubt that you can find a more undervalued biotech on the market.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today